Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
RZLT similar filings
- 25 Apr 24 Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
- 14 Mar 24 Entry into a Material Definitive Agreement
- 11 Mar 24 Regulation FD Disclosure
- 22 Feb 24 Other Events
- 13 Feb 24 Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business Update
Filing view
External links
Exhibit 16.1
March 14, 2024
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read Item 4.01(a) of Form 8-K of Rezolute, Inc. dated March 14, 2024, and agree with the statements concerning our firm contained therein. We have no basis to agree or disagree with other statements of the registrant contained therein.
Very truly yours, | |
/s/ Plante & Moran, PLLC | |
Cleveland, Ohio |